Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India

Launched by POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH · Sep 19, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a group of liver diseases known as Porto-sinusoidal Vascular Disease (PSVD) and how it affects patients in India. Researchers want to see if a new way of classifying these diseases, called the VALDIG classification, works well for Indian patients. They will look at individuals who have been diagnosed with conditions like Non-Cirrhotic Portal Hypertension (NCPH) and other related diseases, using various tests such as liver biopsies and imaging scans. The goal is to better understand these diseases and see if the new classification can help doctors diagnose and treat patients more effectively.

To participate in this trial, you need to be between 12 and 70 years old and have a diagnosis of NCPH based on certain medical tests. However, if you have liver cirrhosis (a serious scarring of the liver) or active cancer, you won't be able to join. Participants can expect to undergo several tests and examinations that will help researchers gather information about their health and how these liver diseases behave. This study is important because it may lead to better diagnosis and treatment options for patients with liver-related issues in India.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of 12-70 years, either gender with clinical, pathological radiological diagnosis of NCPH
• Exclusion Criteria:
• • Any patients having Cirrhosis based on clinical, pathological, or radiological diagnosis
• • Any patients having active malignancy